Position in EDIT
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$595,703
+$350,940 QoQ
Shares Held
183,859
+54.0% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 216 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Derivatives in EDIT
reported options exposure · as of Dec 31, 2025CallValue
$762,805
CallShares
372,100
PutValue
$98,605
PutShares
48,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. EDIT ranks #66 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in EDIT
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $595,703 | 183,859 | Shares | Sole | 2026-08-03 | |
| 2025-12-31 | $244,763 | 119,397 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $762,805 | 372,100 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $98,605 | 48,100 | Put | Sole | 2026-02-13 | |
| 2025-09-30 | $460,122 | 132,600 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $91,955 | 26,500 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $1,366,590 | 393,830 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $104,902 | 82,600 | Call | Sole | 2025-02-13 | |
| 2024-12-31 | $21,209 | 16,700 | Put | Sole | 2025-02-13 | |
| 2024-12-31 | $14,790 | 11,646 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $311,674 | 91,400 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $162,657 | 47,700 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $318,245 | 93,327 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $428,706 | 91,800 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $28,020 | 6,000 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $2,226 | 300 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $142,916 | 19,261 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $359,870 | 48,500 | Call | Sole | 2024-05-15 | |
| 2023-06-30 | $125,919 | 15,300 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $269,700 | 37,200 | Put | Sole | 2023-05-15 | |
| 2023-03-31 | $266,568 | 36,768 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $163,850 | 22,600 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $108,355 | 12,216 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $181,835 | 20,500 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $332,625 | 37,500 | Put | Sole | 2023-02-14 | |
| 2022-09-30 | $1,382,875 | 112,980 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $2,448 | 200 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $106,488 | 8,700 | Put | Sole | 2022-11-14 | |
| 2020-03-31 | $178,470 | 9,000 | Call | Sole | 2020-05-15 | |
| 2020-03-31 | $124,512 | 6,279 | Shares | Sole | 2020-05-15 | |
| 2020-03-31 | $118,980 | 6,000 | Put | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||